Navigation Links
King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Therapeutic Use
Date:6/25/2009

ACUROX(R) and EMBEDA (TM) Data Highlighted at the College on Problems of Drug Dependence Annual Meeting

RENO, Nev., June 25 /PRNewswire/ -- King Pharmaceuticals, Inc. (NYSE: KG) today announced that the Company is presenting safety and efficacy data for ACUROX(R) and EMBEDA(TM) (ALO-01), two novel opioid analgesic formulations that are in development, at the 71st Annual Meeting of the College on Problems of Drug Dependence. King is also developing other pain medicines employing unique technology platforms designed to address risks associated with currently marketed opioids.

"We anticipate that ACUROX(R) and EMBEDA(TM), upon approval, will offer new therapeutic tools for physicians treating people living with pain," said Eric Carter, Chief Science Officer of King Pharmaceuticals. "Our expectation is that these novel technologies could become instrumental in a physician's arsenal of safe and effective pain medicines that can help with an overall risk management plan."

Highlights of King's presentations and King supported presentations are as follows:

ACUROX(R) (oxycodone HCl/niacin) Tablets for the Treatment of Acute, Moderate to Severe Pain Following Bunionectomy Surgery in Adult Patients

ACUROX(R) Tablets are a unique composition of short-acting oxycodone HCl, niacin and functional inactive ingredients intended to relieve moderate to severe pain. A Phase III study evaluated the analgesic efficacy and safety of ACUROX(R) in adults with moderate to severe pain following bunionectomy surgery. The 405 participants received either two ACUROX(R) Tablets 7.5/30 mg, two ACUROX(R) Tablets 5/30 mg or two placebo tablets every six hours for 48 hours after surgery. Both doses of ACUROX(R) Tablets demonstrated significant reduction in pain compared to placebo. The adv
'/>"/>

SOURCE King Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... ApolloDx™ today announced it will unveil and ... event at the company,s office in Salt ... The event, which will start at 10:00 a.m., will ... .    "We believe our mobile diagnostic ... , Co-Founder and Managing Partner of ApolloDx. In addition ...
(Date:8/20/2014)... WORTH, Fla. , Aug. 20, 2014  Glades Drugs, ... , is proud to announce its expansion into a ... , which will feature an 8,000-square-foot office space and state ... currently accepting applications for 100 open positions for the new ... at 4560 Lantana Road will serve as the chain,s corporate ...
(Date:8/20/2014)... Breathe , the fastest growing online sleep apnea shopping destination ... received more than 4.5 million unique page views since the start ... many people are finding our blog and reading our articles," said ... making sleep apnea more widely known and hope that people continue ... news , troubleshooting advice , and new product launches ...
Breaking Medicine Technology:Glades Drugs Moves to New Corporate Headquarters, 100 Open Positions 2Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 2Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 3Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 4
... that a new market research report is available in ... PharmaVitae Profile http://www.reportlinker.com/p0201761/Eli-Lilly--Co-PharmaVitae-Profile.html ... and forecast performance for Eli Lilly in the prescription ... and pipeline analysis and assessment of financial per ...
... Sept. 23 OmniComm Systems, Inc. (OTC: OMCM), ... EDC marketplace, today announced that Beardsworth, a full ... difficult therapeutic areas, has selected OmniComm,s AE Reporting ... Reporting is an advanced adverse event reporting and ...
Cached Medicine Technology:Reportlinker Adds Eli Lilly & Co.: PharmaVitae Profile 2Reportlinker Adds Eli Lilly & Co.: PharmaVitae Profile 3Reportlinker Adds Eli Lilly & Co.: PharmaVitae Profile 4Reportlinker Adds Eli Lilly & Co.: PharmaVitae Profile 5Reportlinker Adds Eli Lilly & Co.: PharmaVitae Profile 6Reportlinker Adds Eli Lilly & Co.: PharmaVitae Profile 7Beardsworth® Selects OmniComm Systems® AE Reporting System 2Beardsworth® Selects OmniComm Systems® AE Reporting System 3
(Date:8/20/2014)... York, NY (PRWEB) August 20, 2014 ... filed on behalf of women who were allegedly injured ... move forward in New Jersey’s Bergen County Superior Court, ... Order issued on August 15, 2014, the Court has ... files for Mirena lawsuits that are part of the ...
(Date:8/20/2014)... Loss of brain cells that act as a "sleep ... falling and staying asleep, a new study suggests. ... and often results in nighttime confusion and wandering, according ... the Rush Memory and Aging Project, which includes nearly ... being followed until death, at which point their brains ...
(Date:8/20/2014)... By Kathleen Doheny ... -- Breast reconstruction after a mastectomy has long been an ... percent of women choose it. "The most common reasons ... important, they weren,t interested in more surgery or they were ... Morrow, chief of breast surgery at Memorial Sloan Kettering Cancer ...
(Date:8/20/2014)... of the most persistent and deadliest infectious diseases in ... year. , Scientists who study tuberculosis have long debated ... from humans in Africa to seals and sea lions ... it to Native people there before Europeans landed on ... Seals as a Source of New World Human Tuberculosis," ...
(Date:8/20/2014)... 20, 2014 With 3943.8% growth, Connexion Point ... the nation’s fastest growing companies. The Inc. 500 ranks Connexion ... sector. Connexion Point is the #1 fastest growing company in ... and Medicaid, and its clients include four of the top ... 1,000 people and has offices and contact centers in Salt ...
Breaking Medicine News(10 mins):Health News:Mirena Lawsuit News: Case Management Order Issued in New Jersey Mirena Litigation, Bernstein Liebhard LLP Reports 2Health News:Mirena Lawsuit News: Case Management Order Issued in New Jersey Mirena Litigation, Bernstein Liebhard LLP Reports 3Health News:Mirena Lawsuit News: Case Management Order Issued in New Jersey Mirena Litigation, Bernstein Liebhard LLP Reports 4Health News:Seniors' Sleep Woes May Be Linked to Loss of Brain Cells 2Health News:Many Women Who Have Mastectomy Don't Get Breast Reconstruction: Study 2Health News:Many Women Who Have Mastectomy Don't Get Breast Reconstruction: Study 3Health News:New research shows seals and sea lions likely spread tuberculosis to humans 2Health News:New research shows seals and sea lions likely spread tuberculosis to humans 3Health News:With 3943.8% Growth, Connexion Point, a Leader in Contact Centers for Health Care, Ranks 86th on the Inc. 500 List as One of the Nation’s Fastest Growing Companies 2
... including Influenza and ... MRSA., ... SILVER SEAL(TM) Washable, Antimicrobial Mouse at the HiMSS,Healthcare Symposium in Orlando, FL. ... mouse to be fully submersible,dishwasher safe, and manufactured from SILVER SEAL(TM) Antimicrobial,plastic. ...
... Inc. (NYSE: WTW ) announced today that David ... Financial,Officer, will present at the Bank of America 2008 ... be held on Tuesday, March 11, 2008 at 4:10 ... webcast on the Company,s,website at http://www.weightwatchersinternational.com . An ...
... data from the Agency for Healthcare Research ... serve a disproportionate share,of seniors and individuals ... full advantage of this increasingly popular and ... Association (PCMA) said,today. At a time when ...
... will accommodate nationwide growth and increased traffic, SUNNYVALE, Calif., ... website. The site,s new design and upgraded features,will allow the ... in 2008.,The site is also designed to accommodate the increased ... over 30% in the last six weeks," says Alison,Guimard, founder ...
... and Corporacion Multi ... campaign success-, GUATEMALA CITY, Feb. 25 Fundacion ... for cancer treatment,of underprivileged children, today announced it raised ... "Unete Para,Salvar Ninos Con Cancer" Mega Lottery. The lottery ...
... Feb. 25 According to the CDC,s latest report,the ... in every state,and a dozen new deaths among children, ... Control and Prevention,s influenza division., Nationally, 49 states ... not reporting widespread influenza; it is at the regional,level, ...
Cached Medicine News:Health News:Seal Shield Introduces New Silver Seal Washable, Antimicrobial Mouse at HiMSS Healthcare Symposium 2Health News:Weight Watchers to Present at Bank of America 2008 Consumer Conference 2Health News:New Government Data: Mail-Service Pharmacies Grow, But Public Programs Lag Behind 2Health News:Guatemala's Fundacion Ayudame a Vivir Fundraising Campaign Raises More Than $2.6 Million 2
... ergonomics, and value!, Comfortable feel and ... handle , Finer control while pipetting with ... tip ejection with long, lever tip ejector ... sterilization without the need for recalibration , ...
Inquire...
... The Finnpipette Digital Multichannel, ... even lighter work of routine ... all these advanced features: Soft-touch ... micro volume pipetting (0.5-10ul models), ...
... ergonomics, and value! , Comfortable feel ... contoured handle , Finer control while pipetting ... Stress-free tip ejection with long, lever tip ... and sterilization without the need for recalibration ...
Medicine Products: